Johnson, Matthew W.

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 2,201

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,301

WITHIN‐SUBJECT COMPARISON OF REAL AND HYPOTHETICAL MONEY REWARDS IN DELAY DISCOUNTING

Johnson, M. W., & Bickel, W. K. (2002) · Journal of the Experimental Analysis of Behavior

Decision-Making and Behavioral EconomicsNeural and Behavioral Psychology Studies

Cited by 991

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 932

Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology

Psychedelics and Drug StudiesSmoking Behavior and Cessation

Cited by 914

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 895

Long-term follow-up of psilocybin-facilitated smoking cessation

Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse

Smoking Behavior and CessationPsychedelics and Drug Studies

Cited by 696

The behavioral economics of substance use disorders: reinforcement pathologies and their repair

Bickel, W. K., Johnson, M. W., Koffarnus, M. N., MacKillop, J., & Murphy, J. G. (2014) · Annual Review of Clinical Psychology

Substance Abuse Treatment and OutcomesDecision-Making and Behavioral Economics

Cited by 655

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 637

Delay discounting in current and never-before cigarette smokers: Similarities and differences across commodity, sign, and magnitude.

Baker, F., Johnson, M. W., & Bickel, W. K. (2003) · Journal of Abnormal Psychology

Decision-Making and Behavioral EconomicsSmoking Behavior and Cessation

Cited by 602

An algorithm for identifying nonsystematic delay-discounting data.

Johnson, M. W., & Bickel, W. K. (2008) · Experimental and Clinical Psychopharmacology

Decision-Making and Behavioral EconomicsNeural and Behavioral Psychology Studies

Cited by 555

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., et al. (2023) · JAMA

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 545

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018) · Journal of Psychopharmacology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 520

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 506

Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.

Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews

Psychedelics and Drug StudiesSmoking Behavior and Cessation

Cited by 476

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up.

Gukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2022) · Journal of Psychopharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 425

Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin

MacLean, K. A., Leoutsakos, J. S., Johnson, M. W., & Griffiths, R. R. (2012) · Journal for the Scientific Study of Religion

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 405

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 366

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018) · Neuropharmacology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 354

Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts

Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. (2018) · Journal of Psychopharmacology

Psychedelics and Drug StudiesSmoking Behavior and Cessation

Cited by 285

Moderate drug use and delay discounting: A comparison of heavy, light, and never smokers.

Johnson, M. W., Bickel, W. K., & Baker, F. (2007) · Experimental and Clinical Psychopharmacology

Decision-Making and Behavioral EconomicsSmoking Behavior and Cessation

Cited by 259

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 226

Psychedelic medicine: a re-emerging therapeutic paradigm

Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. (2015) · Canadian Medical Association Journal

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 187

REPLACING RELATIVE REINFORCING EFFICACY WITH BEHAVIORAL ECONOMIC DEMAND CURVES

Johnson, M. W., & Bickel, W. K. (2006) · Journal of the Experimental Analysis of Behavior

Behavioral and Psychological StudiesDecision-Making and Behavioral Economics

Cited by 187